期刊文献+

恶性腹水的诊治 被引量:5

Diagnosis and Management of Malignant Ascites
下载PDF
导出
摘要 恶性腹水是各种晚期恶性肿瘤的常见表现,其治疗方法虽多,但尚无彻底根治的手段。针对恶性腹水的治疗虽然并不能明显延长患者生存期,但可提高生活质量,临床治疗仍以缓解由恶性腹水所致的症状为主要目的。本文对近年来恶性腹水的诊治现状作一概述。 Malignant ascites is a common manifestation of various advanced malignancies, although multiple treatment modalities are available, none of them can has malignant ascites completely disappear. Therapy of malignant ascites can not significantly prolong the survival rate of patients, but may improve the quality of life. The main purpose of chnical treatment is to amehorate the symptoms caused by malignant ascites. This article reviewed the diagnosis and management of malignant ascites in recent years.
出处 《胃肠病学》 2008年第11期699-700,共2页 Chinese Journal of Gastroenterology
关键词 腹水 诊断 肿瘤 Ascites Diagnosis Neoplasms
  • 相关文献

参考文献11

  • 1Aslam N, Marino CR. Malignant ascites: new concepts in pathophysiology, diagnosis, and management. Arch Intern Med, 2001, 161 (22): 2733-2737.
  • 2Becker G. Medical and palliative management of malignant ascites. Cancer Treat Res, 2007, 134: 459- 467.
  • 3Rosenberg SM. Palliation of malignant ascites. Gastroenterol Clin North Am, 2006, 35 (1): 189-199, xi.
  • 4Smith EM, Jayson GC. The current and future management of malignant ascites. Clin Oncol (R Coll Radiol), 2003, 15 (2): 59-72.
  • 5Becker G, Galandi D, Blum HE. Malignant ascites: systematic review and guideline for treatment. Eur J Cancer, 2006, 42 (5): 589-597.
  • 6Wickremesekera SK, Stubbs RS. Peritoneovenous shunting for malignant ascites. N Z Med J, 1997, 110 (1037): 33-35.
  • 7Link KH, Roitman M, Holtapples M, et al. Intraperitoneal chemotherapy with mitoxantrone in malignant ascites. Surg Oncol Clin N Am, 2003, 12 (3): 865-872, xvi-xvii.
  • 8Beattie GJ, Smyth JF. Phase I study of intraperitoneal metalloproteinase inhibitor BB94 in patients with malignant ascites. Clin Cancer Res, 1998, 4 (8): 1899- 1902.
  • 9Sartori S, Nielsen I, Tassinari D, et al. Evaluation of a standardized protocol of intracavitary recombinant interferon alpha-2b in the palliative treatment of malignant peritoneal effusions. A prospective pilot study. Oncology, 2001, 61 (3): 192-196.
  • 10Burges A, Wimberger P, Kumper C, et al. Effective relief of malignant ascites in patients with advanced ovarian cancer by a trifunctional anti-EpCAM x anti-CD3 antibody: a phase Ⅰ/Ⅱ study. Clin Cancer Res, 2007, 13 (13): 3899-3905.

同被引文献58

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部